282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
نویسندگان
چکیده
منابع مشابه
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
apply to them, it applying for 6 month. Results: All the patient improved their Urticaria between weeks 3 and fort of application of the drug, getting the control of the symptoms between the month 2 and 3 in the 5 patients, without requiring other drugs for their control, and remained asymptomatic for 3 and forth months discontinuity the product up to 6 months, not reactivity the Urticaria, the...
متن کاملOmalizumab for the treatment of severe persistent allergic asthma.
This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of omalizumab for the treatment of chronic severe persistent allergic asthma, in accordance with the licensed indication, based upon the evidence submission from Novartis to the National Institute for Health and Clinical Excellence (NICE) as part of the single technolog...
متن کاملOmalizumab as successful treatment option in severe peanut allergy
Methods We present the case of a girl, who was diagnosed with peanut allergy at age 8 after she developed abdominal pain, urticaria and angioedema following a meal of cornflakes with peanut chips. No food challenge was performed at that time, and she was advised to avoid peanuts. Despite avoiding foods visibly containing peanut, she repeatedly experienced urticaria, burning of the tongue, nause...
متن کاملAppropriate selection for omalizumab treatment in patients with severe asthma?
Background: Omalizumab improves asthma control in patients with uncontrolled severe allergic asthma; however, appropriate patient selection is crucial. Information in this field is sparse. Objective: We aimed to estimate whether potential omalizumab candidates were appropriately selected according to guidelines, and the clinical effect of omalizumab treatment over time. Design: We performed a r...
متن کاملOmalizumab: a treatment for severe asthma in real life?
In 2015, asthma remains an important health problem. It is costly: first as a chronic disorder it represents a significant burden for the patients and their relatives; secondly due to management of disease including controller medications and what is required for acute exacerbations i.e.: hospitalizations and days off work Overall, while mortality has certainly decreased, most of our current tr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Allergy Organization Journal
سال: 2012
ISSN: 1939-4551
DOI: 10.1097/01.wox.0000412039.77501.e1